Regulation of mRNA Translation as a Conserved Mechanism of Longevity Control

  • Ranjana Mehta
  • Devon Chandler-Brown
  • Fresnida J. Ramos
  • Lara S. Shamieh
  • Matt Kaeberlein
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 694)


Appropriate regulation of mRNA translation is essential for growth and survival and the pathways that regulate mRNA translation have been highly conserved throughout eukaryotic evolution. Translation is controlled by a complex set of mechanisms acting at multiple levels, ranging from global protein synthesis to individual mRNAs. Recently, several mutations that perturb regulation of mRNA translation have also been found to increase longevity in three model organisms: the budding yeast Saccharomyces cerevisiae, the nematode Caenorhabditis elegans and the fruit fly Drosophila melanogaster. Many of these translation control factors can be mapped to a single pathway downstream of the nutrient responsive target of rapamycin (TOR) kinase. In this chapter, we will review the data suggesting that mRNA translation is an evolutionarily conserved modifier of longevity and discuss potential mechanisms by which mRNA translation could influence aging and age-associated disease in different species.


Caloric Restriction Spinal Muscular Atrophy Tuberous Sclerosis Complex mRNA Translation Life Span Extension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bohr VA, Anson RM. DNA damage, mutation and fine structure DNA repair in aging. Mutat Res 1995; 338:25–34.PubMedGoogle Scholar
  2. 2.
    de Magalhaes JP, Faragher RG. Cell divisions and mammalian aging: integrative biology insights from genes that regulate longevity. Bioessays 2008; 30:567–78.PubMedGoogle Scholar
  3. 3.
    Jeyapalan JC, Sedivy JM. Cellular senescence and organismal aging. Mech Ageing Dev 2008; 129:467–74.PubMedGoogle Scholar
  4. 4.
    Morimoto RI, Cuervo AM. Protein homeostasis and aging: taking care of proteins from the cradle to the grave. J Gerontol A Biol Sci Med Sci 2009; 64:167–70.PubMedGoogle Scholar
  5. 5.
    Ramasamy R, Vannucci SJ, Yan SS et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration and inflammation. Glycobiology 2005; 15:16R–28R.PubMedGoogle Scholar
  6. 6.
    Sohal RS, Weindruch R. Oxidative stress, caloric restriction and aging. Science 1996; 273:59–63.PubMedGoogle Scholar
  7. 7.
    Warner HR. Superoxide dismutase, aging and degenerative disease. Free Radic Biol Med 1994; 17:249–58.PubMedGoogle Scholar
  8. 8.
    Kaeberlein M. Genome-wide approaches to understanding human ageing. Hum Genomics 2006; 2:422–8.PubMedGoogle Scholar
  9. 9.
    Masoro EJ. Overview of caloric restriction and ageing. Mech Ageing Dev 2005; 126:913–22.PubMedGoogle Scholar
  10. 10.
    Weindruch RH, Walford RL. The Retardation of Aging and Disease by Dietary Restriction. (Thomas, Springfield, IL., 1988).Google Scholar
  11. 11.
    Colman RJ, Beasley TM, Allison DB et al. Attenuation of sarcopenia by dietary restriction in rhesus monkeys. J Gerontol A Biol Sci Med Sci 2008; 63:556–9.PubMedGoogle Scholar
  12. 12.
    Ingram DK, Young J, Mattison JA. Calorie restriction in nonhuman primates: assessing effects on brain and behavioral aging. Neuroscience 2007; 145:1359–64.PubMedGoogle Scholar
  13. 13.
    Messaoudi I, Warner J, Fischer M et al. Delay of T-cell senescence by caloric restriction in aged long-lived nonhuman primates. Proc Natl Acad Sci USA 2006; 103:19448–53.PubMedGoogle Scholar
  14. 13a.
    Colman RJ, Anderson RM, Johnson SC, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009; 325:201–4.PubMedGoogle Scholar
  15. 14.
    Hansen M, Taubert S, Crawford D et al. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell 2007; 6:95–110.PubMedGoogle Scholar
  16. 15.
    Kaeberlein M, Powers RW 3rd, Steffen KK et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 2005; 310:1193–6.PubMedGoogle Scholar
  17. 16.
    Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124:471–84.PubMedGoogle Scholar
  18. 17.
    Hansen M, Chandra A, Mitic LL et al. A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS Genet 2008; 4:e24.PubMedGoogle Scholar
  19. 18.
    Jia K, Levine B. Autophagy is required for dietary restriction-mediated life span extension in C. elegans. Autophagy 2007; 3:597–9.PubMedGoogle Scholar
  20. 19.
    Meléndez A, Tallóczy Z, Seaman M et al. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 2003; 301:1387–91.PubMedGoogle Scholar
  21. 20.
    Kaeberlein M, Kennedy BK. Protein translation, 2007. Aging Cell 2007; 6:731–4.PubMedGoogle Scholar
  22. 21.
    Winzeler EA, Shoemaker DD, Astromoff A et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999; 285:901–6.PubMedGoogle Scholar
  23. 22.
    Kaeberlein M, Kennedy BK. Large-scale identification in yeast of conserved ageing genes. Mech Ageing Dev 2005; 126:17–21.PubMedGoogle Scholar
  24. 23.
    Powers RW 3rd, Kaeberlein M, Caldwell SD et al. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev 2006; 20:174–84.PubMedGoogle Scholar
  25. 24.
    Kaeberlein M. in Handbook of models for human aging (ed. Conn, P.M.) 109–120 (Elsevier Press, Boston, 2006).Google Scholar
  26. 25.
    Fabrizio P, Longo VD. The chronological life span of Saccharomyces cerevisiae. Aging Cell 2003; 2:73–81.PubMedGoogle Scholar
  27. 26.
    Ashrafi K, Sinclair D, Gordon JI et al. Passage through stationary phase advances replicative aging in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1999; 96:9100–5.PubMedGoogle Scholar
  28. 27.
    Jazwinski SM. Molecular mechanisms of yeast longevity. Trends Microbiol 1999; 7:247–52.PubMedGoogle Scholar
  29. 28.
    Jazwinski SM. Yeast longevity and aging—the mitochondrial connection. Mech Ageing Dev 2005; 126:243–8.PubMedGoogle Scholar
  30. 29.
    Steinkraus KA, Kaeberlein M, Kennedy BK. Replicative aging in yeast: the means to the end. Annu Rev Cell Dev Biol 2008; 24:29–54.PubMedGoogle Scholar
  31. 30.
    Kamath RS, Fraser AG, Dong Y et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 2003; 421:231–7.PubMedGoogle Scholar
  32. 31.
    Rual JF, Ceron J, Koreth J et al. Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res 2004; 14:2162–8.PubMedGoogle Scholar
  33. 32.
    Chen D, Pan KZ, Palter JE et al. Longevity determined by developmental arrest genes in Caenorhabditis elegans. Aging Cell 2007; 6:525–33.PubMedGoogle Scholar
  34. 33.
    Curran SP, Ruvkun G. Lifespan regulation by evolutionarily conserved genes essential for viability. PLoS Genet 2007; 3:e56.PubMedGoogle Scholar
  35. 34.
    Dillin A, Hsu AL, Arantes-Oliveira N et al. Rates of behavior and aging specified by mitochondrial function during development. Science 2002; 298:2398–401.PubMedGoogle Scholar
  36. 35.
    Hamilton B et al. A systematic RNAi screen for longevity genes in C. elegans. Genes Dev 2005; 19:1544–55.PubMedGoogle Scholar
  37. 36.
    Hansen M, Hsu AL, Dillin A et al. New genes tied to endocrine, metabolic and dietary regulation of lifespan from a Caenorhabditis elegans genomic RNAi screen. PLoS Genet 2005; 1:119–28.PubMedGoogle Scholar
  38. 37.
    Lee SS et al. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet 2003; 33:40–8.PubMedGoogle Scholar
  39. 38.
    Jia K, Chen D, Riddle DL. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 2004; 131:3897–906.PubMedGoogle Scholar
  40. 39.
    Vellai T, Takacs-Vellai K, Zhang Y et al. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 2003; 426:620.PubMedGoogle Scholar
  41. 40.
    Fabrizio P, Pletcher SD, Minois N et al. Chronological aging-independent replicative life span regulation by Msn2/Msn4 and Sod2 in Saccharomyces cerevisiae. FEBS Lett 2004; 557:136–42.PubMedGoogle Scholar
  42. 41.
    Fabrizio P, Pozza F, Pletcher SD et al. Regulation of longevity and stress resistance by Sch9 in yeast. Science 2001; 292:288–90.PubMedGoogle Scholar
  43. 42.
    Kapahi P, Zid BM, Harper T et al. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 2004; 14:885–90.PubMedGoogle Scholar
  44. 43.
    Pan KZ, Palter JE, Rogers AN et al. Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 2007; 6:111–9.PubMedGoogle Scholar
  45. 44.
    Syntichaki P, Troulinaki K, Tavernarakis N. eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans. Nature 2007; 445:922–6.PubMedGoogle Scholar
  46. 45.
    Chiocchetti A, Zhou J, Zhu H et al. Ribosomal proteins Rpl10 and Rps6 are potent regulators of yeast replicative life span. Exp Gerontol 2006.Google Scholar
  47. 46.
    Managbanag JR, Witten TM, Bonchev D et al. Shortest-path network analysis is a useful approach toward identifying genetic determinants of longevity. PLoS ONE 2008; 3:e3802.PubMedGoogle Scholar
  48. 47.
    Steffen KK, MacKay VL, Kerr EO et al. Yeast life span extension by depletion of 60s ribosomal subunits is mediated by Gcn4. Cell 2008; 133:292–302.PubMedGoogle Scholar
  49. 48.
    Smith ED, Tsuchiya M, Fox LA et al. Quantitative evidence for conserved longevity pathways between divergent eukaryotic species. Genome Res 2008; 18:564–70.PubMedGoogle Scholar
  50. 49.
    Urban J, Soulard A, Huber A et al. Sch9 is a major target of TORC1 in Saccharomyces cerevisiae. Mol Cell 2007; 26:663–74.PubMedGoogle Scholar
  51. 50.
    Chiocchetti A, Zhou J, Zhu H et al. Ribosomal proteins Rpl10 and Rps6 are potent regulators of yeast replicative life span. Exp Gerontol 2007; 42:275–86.PubMedGoogle Scholar
  52. 51.
    Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000; 289:2126–8.PubMedGoogle Scholar
  53. 52.
    Lin SJ et al. Calorie restriction extends Saccharomyces cerevisiae life span by increasing respiration. Nature 2002; 418:344–48.PubMedGoogle Scholar
  54. 53.
    Jiang JC, Jaruga E, Repnevskaya MV et al. An intervention resembling caloric restriction prolongs life span and retards aging in yeast. FASEB J 2000; 14:2135–7.PubMedGoogle Scholar
  55. 54.
    Kaeberlein M, Kirkland KT, Fields S et al. Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol 2004; 2:E296.PubMedGoogle Scholar
  56. 55.
    Kaeberlein TL, Smith ED, Tsuchiya M et al. Lifespan extension in Caenorhabditis elegans by complete removal of food. Aging Cell 2006.Google Scholar
  57. 56.
    Lee GD, Wilson MA, Zhu M et al. Dietary deprivation extends lifespan in Caenorhabditis elegans. Aging Cell 2006.Google Scholar
  58. 57.
    Greer EL, Brunet A. Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans. Aging Cell 2009; 8:113–27.PubMedGoogle Scholar
  59. 58.
    Avruch J, Hara K, Lin Y et al. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 2006; 25:6361–72.PubMedGoogle Scholar
  60. 59.
    Mehta R, Steinkraus KA, Sutphin GL et al. Proteasomal regulation of the hypoxic response modulates aging in C. elegans. Science 2009.Google Scholar
  61. 60.
    Juhasz G, Erdi B, Sass M et al. Atg7-dependent autophagy promotes neuronal health, stress tolerance and longevity but is dispensable for metamorphosis in Drosophila. Genes Dev 2007; 21:3061–6.PubMedGoogle Scholar
  62. 61.
    Morck C, Pilon M. C. elegans feeding defective mutants have shorter body lengths and increased autophagy. BMC Dev Biol 2006; 6:39.PubMedGoogle Scholar
  63. 62.
    Takeshige K, Baba M, Tsuboi S et al. Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. J Cell Biol 1992; 119:301–11.PubMedGoogle Scholar
  64. 63.
    Hinnebusch AG. Translational regulation of yeast GCN4. A window on factors that control initiator-trna binding to the ribosome. J Biol Chem 1997; 272:21661–4.PubMedGoogle Scholar
  65. 64.
    Yang R, Wek SA, Wek RC. Glucose limitation induces GCN4 translation by activation of Gcn2 protein kinase. Mol Cell Biol 2000; 20:2706–17.PubMedGoogle Scholar
  66. 65.
    Shimizu YI, Morita M, Ohmi A et al. Fasting induced up-regulation of activating transcription factor 5 in mouse liver. Life Sci 2009.Google Scholar
  67. 66.
    Zhou D, Palam LR, Jiang L et al. Phosphorylation of eIF2 directs ATF5 translational control in response to diverse stress conditions. J Biol Chem 2008; 283:7064–73.PubMedGoogle Scholar
  68. 67.
    Bilanges B, Argonza-Barrett R, Kolesnichenko M et al. Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and-independent manner. Mol Cell Biol 2007; 27:5746–64.PubMedGoogle Scholar
  69. 68.
    Balch WE, Morimoto RI, Dillin A et al. Adapting proteostasis for disease intervention. Science 2008; 319:916–9.PubMedGoogle Scholar
  70. 69.
    Cohen E, Bieschke J, Perciavalle RM et al. Opposing activities protect against age-onset proteotoxicity. Science 2006; 313:1604–10.PubMedGoogle Scholar
  71. 70.
    Hsu AL, Murphy CT, Kenyon C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 2003; 300:1142–5.PubMedGoogle Scholar
  72. 71.
    Morley JF, Morimoto RI. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol Biol Cell 2004; 15:657–64.PubMedGoogle Scholar
  73. 72.
    Steinkraus KA, Smith ED, Davis C et al. Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf—1-dependent mechanism in Caenorhabditis elegans. Aging Cell 2008.Google Scholar
  74. 73.
    Ravikumar B, Vacher C, Berger Z et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 2004; 36:585-95.Google Scholar
  75. 74.
    King MA, Hands S, Hafiz F et al. Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis. Mol Pharmacol 2008; 73:1052–63.PubMedGoogle Scholar
  76. 75.
    Barbet NC, Schneider U, Helliwell SB et al. TOR controls translation initiation and early G1 progression in yeast. Mol Biol Cell 1996; 7:25–42.PubMedGoogle Scholar
  77. 76.
    Dennis PB, Fumagalli S, Thomas G. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr Opin Genet Dev 1999; 9:49–54.PubMedGoogle Scholar
  78. 77.
    Holcik M, Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 2005; 6:318–27.PubMedGoogle Scholar
  79. 78.
    Barnes AI, Partridge L. Costing reproduction. Animal Behaviour 2003; 66:199–204.Google Scholar
  80. 79.
    Kenyon C. The plasticity of aging: Insights from long-lived mutants. Cell 2005; 120:449–460.PubMedGoogle Scholar
  81. 80.
    Friberg J. in Umeå Centre for Molecular Pathogenesis 39 (Umea University, Umea, 2006).Google Scholar
  82. 81.
    Pan KZ, Palter JE, Rogers AN et al. Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 2007; 6:111–119.PubMedGoogle Scholar
  83. 82.
    Jastrzebski K, Hannan KM, Tchoubrieva EB et al. Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function. Growth Factors 2007; 25:209–26.PubMedGoogle Scholar
  84. 83.
    Weindruch R, Walford RL. The Retardation of Aging and Disease by Dietary Restriction. Springfield: Charles C. Thomas, 1988.Google Scholar
  85. 84.
    Spindler SR. Rapid and reversible induction of the longevity, anticancer and genomic effects of caloric restriction. Mech Ageing Dev 2005; 126:960–6.PubMedGoogle Scholar
  86. 85.
    Guertin DA, Sabatini DM. An expanding role for mTOR in cancer. Trends Mol Med 2005; 11:353–61.PubMedGoogle Scholar
  87. 86.
    Sampson JR, Patel A, Mee AD. Multifocal renal cell carcinoma in sibs from a chromosome 9 linked (TSC1) tuberous sclerosis family. J Med Genet 1995; 32:848–50.PubMedGoogle Scholar
  88. 87.
    Al-Saleem T, Wessner LL, Scheithauer BW et al. Malignant tumors of the kidney, brain and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer 1998; 83:2208–16.PubMedGoogle Scholar
  89. 88.
    Daido S, Yamamoto A, Fujiwara K et al. Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res 2005; 65:4368–75.PubMedGoogle Scholar
  90. 89.
    Mita MM, Mita AC, Chu QS et al. Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies. J Clin Oncol 2008; 26:361–7.PubMedGoogle Scholar
  91. 90.
    Yamamoto S, Tomita Y, Hoshida Y et al. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. Clin Cancer Res 2004; 10:2846–50.PubMedGoogle Scholar
  92. 91.
    Vasko V, Saji M, Hardy E et al. Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer. J Med Genet 2004; 41:161–70.PubMedGoogle Scholar
  93. 92.
    Zhou BP, Liao Y, Xia W et al. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 2001; 3:245–52.PubMedGoogle Scholar
  94. 93.
    Faried LS, Faried A, Kanuma T et al. Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy. Oncol Rep 2006; 16:57–63.PubMedGoogle Scholar
  95. 94.
    Blando J, Portis M, Benavides F et al. PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth. Am J Pathol 2009; 174:1869–79.PubMedGoogle Scholar
  96. 95.
    Ebi H, Tomida S, Takeuchi T et al. Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses. Cancer Res 2009; 69:4027–35.PubMedGoogle Scholar
  97. 96.
    Kim SH, Zukowski K, Novak RF. Rapamycin effects on mTOR signaling in benign, premalignant and malignant human breast epithelial cells. Anticancer Res 2009; 29:1143–50.PubMedGoogle Scholar
  98. 97.
    Meier F, Guenova E, Clasen S et al. Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients. J Am Acad Dermatol 2009; 60:863–8.PubMedGoogle Scholar
  99. 98.
    Raimondi AR, Molinolo A, Gutkind JS. Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model. Cancer Res 2009; 69:4159–66.PubMedGoogle Scholar
  100. 99.
    McDaniel ML, Marshall CA, Pappan KL et al. Metabolic and autocrine regulation of the mammalian target of rapamycin by pancreatic beta-cells. Diabetes 2002; 51:2877–85.PubMedGoogle Scholar
  101. 100.
    Briaud I, Dickson LM, Lingohr MK et al. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells. J Biol Chem 2005; 280:2282–93.PubMedGoogle Scholar
  102. 101.
    Manning BD. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol 2004; 167:399–403.PubMedGoogle Scholar
  103. 102.
    Harrington LS, Findlay GM, Gray A et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 2004; 166:213–23.PubMedGoogle Scholar
  104. 103.
    Pende M, Kozma SC, Jaquet M et al. Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 2000; 408:994–7.PubMedGoogle Scholar
  105. 104.
    Um SH, Frigerio F, Watanabe M et al. Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity. Nature 2004; 431:200–5.PubMedGoogle Scholar
  106. 105.
    Tsukiyama-Kohara K, Poulin F, Kohara M et al. Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med 2001; 7:1128–32.PubMedGoogle Scholar
  107. 106.
    Cho HJ, Park J, Lee HW et al. Regulation of adipocyte differentiation and insulin action with rapamycin. Biochem Biophys Res Commun 2004; 321:942–8.PubMedGoogle Scholar
  108. 107.
    Kim JE, Chen J. regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 2004; 53:2748–56.PubMedGoogle Scholar
  109. 108.
    Polak P, Cybulski N, Feige JN et al. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab 2008; 8:399–410.PubMedGoogle Scholar
  110. 109.
    Guertin DA, Stevens DM, Thoreen CC et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 2006; 11:859–71.PubMedGoogle Scholar
  111. 110.
    Bentzinger CF, Romanino K, Cloëtta D et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 2008; 8:411–24.PubMedGoogle Scholar
  112. 111.
    Shioi T, McMullen JR, Tarnavski O et al. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 2003; 107:1664–70.PubMedGoogle Scholar
  113. 112.
    Sanada S, Node K, Asanuma H et al. Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase. J Am Coll Cardiol 2002; 40:991–7.PubMedGoogle Scholar
  114. 113.
    Gao XM, Wong G, Wang B et al. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. J Hypertens 2006; 24:1663–70.PubMedGoogle Scholar
  115. 114.
    Gillette-Guyonnet S, Vellas B. Caloric restriction and brain function. Curr Opin Clin Nutr Metab Care 2008; 11:686–92.PubMedGoogle Scholar
  116. 115.
    Levenson CW, Rich NJ. Eat less, live longer? New insights into the role of caloric restriction in the brain. Nutr Rev 2007; 65:412–5.PubMedGoogle Scholar
  117. 116.
    Malagelada C, Jin ZH, Greene LA. RTP801 is induced in Parkinson’s disease and mediates neuron death by inhibiting Akt phosphorylation/activation. J Neurosci 2008; 28:14363–71.PubMedGoogle Scholar
  118. 117.
    Millino C, Fanin M, Vettori A et al. Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy. BMC Med 2009; 7:14.PubMedGoogle Scholar
  119. 118.
    Sarkar S, Ravikumar B, Rubinsztein DC. Autophagic clearance of aggregate-prone proteins associated with neurodegeneration. Methods Enzymol 2009; 453:83–110.PubMedGoogle Scholar
  120. 119.
    Bonini NM, La Spada AR. Silencing polyglutamine degeneration with RNAi. Neuron 2005; 48:715–8.PubMedGoogle Scholar
  121. 120.
    Cheng-Lai A, Frishman WH. Sirolimus-eluting coronary stents: novel devices for the management of coronary artery disease. Am J Ther 2004; 11:218–28.PubMedGoogle Scholar
  122. 121.
    Weil RJ. Incorporating molecular tools into early-stage clinical trials. PLoS Med 2008; 5:e21.PubMedGoogle Scholar
  123. 122.
    Miller RA, Harrison DE, Astle CM et al. An aging interventions testing program: study design and interim report. Aging Cell 2007; 6:565–75.PubMedGoogle Scholar
  124. 123.
    Syntichaki P, Troulinaki K, Tavernarakis N. Protein synthesis is a novel determinant of aging in Caenorhabditis elegans. Ann N Y Acad Sci 2007; 1119:289–95.PubMedGoogle Scholar
  125. 124.
    Tavernarakis N. Ageing and the regulation of protein synthesis: a balancing act? Trends Cell Biol 2008; 18:228–35.PubMedGoogle Scholar
  126. 125.
    Kim Y, Sun H. Functional genomic approach to identify novel genes involved in the regulation of oxidative stress resistance and animal lifespan. Aging Cell 2007; 6:489–503.PubMedGoogle Scholar
  127. 126.
    Gangloff YG, Mueller M, Dann SG et al. Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol 2004; 24:9508–16.PubMedGoogle Scholar
  128. 127.
    Murakami M, Ichisaka T, Maeda M et al. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 2004; 24:6710–8.PubMedGoogle Scholar
  129. 128.
    Shima H, Pende M, Chen Y et al. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 1998; 17:6649–59.PubMedGoogle Scholar
  130. 129.
    Pende M, Um SH, Mieulet V et al. S6K1(−/−)/S6K2(−/−) mice exhibit perinatal lethality and rapamycin-sensitive 5’-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 2004; 24:3112–24.PubMedGoogle Scholar
  131. 130.
    Gandin V, Miluzio A, Barbieri AM et al. Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation. Nature 2008; 455:684–8.PubMedGoogle Scholar
  132. 131.
    Le Bacquer O, Petroulakis E, Paglialunga S et al. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J Clin Invest 2007; 117:387–96.PubMedGoogle Scholar
  133. 132.
    Anderson SJ, Lauritsen JP, Hartman MG et al. Ablation of ribosomal protein L22 selectively impairs alphabeta T-cell development by activation of a p53-dependent checkpoint. Immunity 2007; 26:759–72.PubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2010

Authors and Affiliations

  • Ranjana Mehta
    • 1
  • Devon Chandler-Brown
    • 1
  • Fresnida J. Ramos
    • 1
  • Lara S. Shamieh
    • 1
  • Matt Kaeberlein
    • 1
  1. 1.Department of PathologyUniversity of WashingtonSeattleUSA

Personalised recommendations